Market Research Reports, Inc.

Global Vinblastinesulphate Market Will Grow at a CAGR 1.6% and Reach USD 21 Million by 2023, from USD 19 Million in 2017

New Global Vinblastinesulphate (CAS 143-67-9) Consumption Market 2023 Report Covers market forecast and top Companies like Masimo Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical and others.


Lewes, DE -- (SBWIRE) -- 12/12/2018 -- Global Vinblastinesulphate (CAS 143-67-9) Market will register a 1.6% CAGR in terms of revenue, reach US$ 21 million by 2023, from US$ 19 million in 2017.

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn't survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.

Over the next five years, study projects that Vinblastinesulphate (CAS 143-67-9) will register a 1.6% CAGR in terms of revenue, reach US$ 21 million by 2023, from US$ 19 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Vinblastinesulphate (CAS 143-67-9) market by product type, application, key manufacturers and key regions.

To calculate the market size, study considers value and volume generated from the sales of the following segments:

Segmentation by product type:
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Segmentation by application:
Lung Cancer
Breast & Ovarian Cancer

This report also splits the market by region:
United States
Southeast Asia
Middle East & Africa
South Africa
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Vinblastinesulphate (CAS 143-67-9) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Vinblastinesulphate (CAS 143-67-9) market by identifying its various subsegments.
Focuses on the key global Vinblastinesulphate (CAS 143-67-9) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vinblastinesulphate (CAS 143-67-9) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vinblastinesulphate (CAS 143-67-9) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Spanning over 133 pages "Forecast of Global Vinblastinesulphate (CAS 143-67-9) Consumption Market 2023" report covers Scope of the Report, Executive Summary, Global Vinblastinesulphate (CAS 143-67-9) by Players, Vinblastinesulphate (CAS 143-67-9) by Regions, Market Drivers, Challenges and Trends, Marketing, Distributors and Customer, Global Vinblastinesulphate (CAS 143-67-9) Market Forecast, Key Players Analysis, Research Findings and Conclusion.

Please visit this link for more details:

Find all Chemicals Reports at:

For related reports please visit:

Read our Interactive Market Research Blog

About is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: